The potential use of novel chitosan-coated deformable liposomes in an ocular drug delivery system

Colloids and Surfaces B: Biointerfaces

Volumn 143, Issue , 2016, Pages 455-462

  Chen, Hongdan ^a   Pan, Hao ^a,b   Li, Panpan ^a   Wang, Hui ^c   Wang, Xin ^a   Pan, Weisan ^a   Yuan, Yue ^a  

^a SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

^b QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^c UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Deformable liposomes; Edge activator; Gamma scintigraphy; Ocular tolerance; Penetration enhancement; Pre corneal retention

Indexed keywords

CHITIN; CHITOSAN; DEFORMATION; DRUG PRODUCTS; ENCAPSULATION; NUCLEAR MEDICINE; PARTICLE SIZE; PARTICLE SIZE ANALYSIS;

DEFORMABLE LIPOSOMES; EDGE ACTIVATORS; GAMMA SCINTIGRAPHIES; PENETRATION ENHANCEMENTS; PRE-CORNEAL RETENTION;

LIPOSOMES;

ALCOHOL; CHITOSAN; FLURBIPROFEN; LIPOSOME;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORNEA; DRUG ELIMINATION; DRUG FORMULATION; DRUG PENETRATION; DRUG RETENTION; DRUG SOLUTION; DRUG STABILITY; ENCAPSULATION; EYE IRRITATION; IN VIVO STUDY; LIPOSOMAL DELIVERY; MALE; MATERIAL COATING; NEW ZEALAND WHITE (RABBIT); NONHUMAN; OCULAR DRUG DELIVERY SYSTEM; OPHTHALMIC DRUG DELIVERY DEVICE; PARTICLE SIZE; PRIORITY JOURNAL; ZETA POTENTIAL; ANIMAL; CHEMISTRY; DRUG DELIVERY SYSTEM; DRUG EFFECTS; DRUG RELEASE; INTRAOCULAR DRUG ADMINISTRATION; LEPORIDAE; METABOLISM; PERMEABILITY; TISSUE CULTURE TECHNIQUE;

ADMINISTRATION, OPHTHALMIC; ANIMALS; CHITOSAN; CORNEA; DRUG COMPOUNDING; DRUG DELIVERY SYSTEMS; DRUG LIBERATION; FLURBIPROFEN; LIPOSOMES; MALE; PARTICLE SIZE; PERMEABILITY; RABBITS; TISSUE CULTURE TECHNIQUES;

EID: 84962319185     PISSN: 09277765     EISSN: 18734367     Source Type: Journal    
DOI: 10.1016/j.colsurfb.2016.03.061     Document Type: Article

References (26)

1. Gratieri T., Gelfuso G.M., Rocha E.M., Sarmento V.H., de Freitas O., Lopez R.F. A poloxamer/chitosan in situ forming gel with prolonged retention time for ocular delivery. Eur. J. Pharm. Biopharm. 2010, 75:186-193.
2. Kaur I.P., Rana C., Singh M., Bhushan S., Singh H., Kakkar S. Development and evaluation of novel surfactant-based elastic vesicular system for ocular delivery of fluconazole. J. Ocul. Pharmacol. Ther. 2012, 28:484-496.
3. Luo Q., Zhao J., Zhang X., Pan W. Nanostructured lipid carrier (NLC) coated with Chitosan Oligosaccharides and its potential use in ocular drug delivery system. Int. J. Pharm. 2011, 403:185-191.
4. Gupta H., Aqil M., Khar R.K., Ali A., Bhatnagar A., Mittal G. An alternative in situ gel-formulation of levofloxacin eye drops for prolong ocular retention. J. Pharm. Bioallied. Sci. 2015, 7:9-14.
5. Kalam M.A., Alshamsan A., Aljuffali I.A., Mishra A.K., Sultana Y. Delivery of gatifloxacin using microemulsion as vehicle: formulation, evaluation, transcorneal permeation and aqueous humor drug determination. Drug Deliv. 2014, 1-12.
6. Nan K., Ma F., Hou H., Freeman W.R., Sailor M.J., Cheng L. Porous silicon oxide-PLGA composite microspheres for sustained ocular delivery of daunorubicin. Acta Biomater. 2014, 10:3505-3512.
7. Nicolosi D., Cupri S., Genovese C., Tempera G., Mattina R., Pignatello R. Nanotechnology approaches for antibacterial drug delivery: preparation and microbiological evaluation of fusogenic liposomes carrying fusidic acid. Int. J. Antimicrob. Agents 2015, 45:622-626.
8. Wang F., Chen L., Zhang D., Jiang S., Shi K., Huang Y., Li R., Xu Q. Methazolamide-loaded solid lipid nanoparticles modified with low-molecular weight chitosan for the treatment of glaucoma: vitro and vivo study. J. Drug Target. 2014, 22:849-858.
9. Qi H., Chen W., Huang C., Li L., Chen C., Li W., Wu C. Development of a poloxamer analogs/carbopol-based in situ gelling and mucoadhesive ophthalmic delivery system for puerarin. Int. J. Pharm. 2007, 337:178-187.
10. Shen Y., Tu J. Preparation and ocular pharmacokinetics of ganciclovir liposomes. AAPS J. 2007, 9:E371-377.
11. Dai Y., Zhou R., Liu L., Lu Y., Qi J., Wu W. Liposomes containing bile salts as novel ocular delivery systems for tacrolimus (FK506): in vitro characterization and improved corneal permeation. Int. J. Nanomed. 2013, 8:1921-1933.
12. Kakkar S., Kaur I.P. Spanlastics-a novel nanovesicular carrier system for ocular delivery. Int. J. Pharm. 2011, 413:202-210.
13. Perez A.P., Altube M.J., Schilrreff P., Apezteguia G., Celes F.S., Zacchino S., de Oliveira C.I., Romero E.L., Morilla M.J. Topical amphotericin B in ultradeformable liposomes: formulation, skin penetration study, antifungal and antileishmanial activity in vitro. Colloids Surf. B Biointerfaces 2015, 139:190-198.
14. Wang J.J., Zeng Z.W., Xiao R.Z., Xie T., Zhou G.L., Zhan X.R., Wang S.L. Recent advances of chitosan nanoparticles as drug carriers. Int. J. Nanomed. 2011, 6:765-774.
15. Janes K.A., Calvo P., Alonso M.J. Polysaccharide colloidal particles as delivery systems for macromolecules. Adv. Drug Deliv. Rev. 2001, 47:83-97.
16. Kumar K., Dhawan N., Sharma H., Vaidya S., Vaidya B. Bioadhesive polymers: novel tool for drug delivery. Artif. Cells Nanomed. Biotechnol. 2014, 42:274-283.
17. Zhao G.D., Sun R., Ni S.L., Xia Q. Development and characterisation of a novel chitosan-coated antioxidant liposome containing both coenzyme Q10 and alpha-lipoic acid. J. Microencapsul. 2015, 32:157-165.
18. Li N., Zhuang C., Wang M., Sun X., Nie S., Pan W. Liposome coated with low molecular weight chitosan and its potential use in ocular drug delivery. Int. J. Pharm. 2009, 379:131-138.
19. Costa J.R., Silva N.C., Sarmento B., Pintado M. Potential chitosan-coated alginate nanoparticles for ocular delivery of daptomycin. Eur. J. Clin. Microbiol. Infect. Dis. 2015, 34:1255-1262.
20. Hermans K., Van den Plas D., Kerimova S., Carleer R., Adriaensens P., Weyenberg W., Ludwig A. Development and characterization of mucoadhesive chitosan films for ophthalmic delivery of cyclosporine A. Int. J. Pharm. 2014, 472:10-19.
21. Majumdar S., Hippalgaonkar K., Repka M.A. Effect of chitosan, benzalkonium chloride and ethylenediaminetetraacetic acid on permeation of acyclovir across isolated rabbit cornea. Int. J. Pharm. 2008, 348:175-178.
22. Jaafar-Maalej C., Diab R., Andrieu V., Elaissari A., Fessi H. Ethanol injection method for hydrophilic and lipophilic drug-loaded liposome preparation. J. Liposome Res. 2010, 20:228-243.
23. Gillet A., Grammenos A., Compere P., Evrard B., Piel G. Development of a new topical system: drug-in-cyclodextrin-in-deformable liposome. Int. J. Pharm. 2009, 380:174-180.
24. El Zaafarany G.M., Awad G.A., Holayel S.M., Mortada N.D. Role of edge activators and surface charge in developing ultradeformable vesicles with enhanced skin delivery. Int. J. Pharm. 2010, 397:164-172.
25. Manosroi A., Jantrawut P., Manosroi J. Anti-inflammatory activity of gel containing novel elastic niosomes entrapped with diclofenac diethylammonium. Int. J. Pharm. 2008, 360:156-163.
26. Artursson P., Lindmark T., Davis S.S., Illum L. Effect of chitosan on the permeability of monolayers of intestinal epithelial cells (Caco-2). Pharm. Res. 1994, 11:1358-1361.